If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where hiroshi ariyama is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles
oxaliplatin Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Stomach Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences
Cisplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

  • 673 Citations
  • 14 h-Index
  • 61 Article
8 Citations (Scopus)

Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer

Nakano, M., Kikushige, Y., Miyawaki, K., Kunisaki, Y., Mizuno, S., Takenaka, K., Tamura, S., Okumura, Y., Ito, M., ariyama, H., Kusaba, H., Nakamura, M., Maeda, T., Baba, E. & Akashi, K., Feb 7 2019, In : Oncogene. 38, 6, p. 780-793 14 p.

Research output: Contribution to journalArticle

Neoplastic Stem Cells
Transforming Growth Factor beta
Colorectal Neoplasms
Stem Cells
Organoids

Efficacy and safety of ramucirumab plus modified FOLFIRI for metastatic colorectal cancer

Yoshihiro, T., Kusaba, H., Makiyama, A., Kobayashi, K., Uenomachi, M., Ito, M., Doi, Y., Mitsugi, K., Aikawa, T., Takayoshi, K., Esaki, T., Shimokawa, H., Tsuchihashi, K., ariyama, H., Akashi, K. & Baba, E., May 15 2019, In : International Journal of Clinical Oncology. 24, 5, p. 508-515 8 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Safety
irinotecan
Confidence Intervals
ramucirumab
5 Citations (Scopus)

Activation of central/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibody

Yamaguchi, K., Mishima, K., Ohmura, H., Hanamura, F., Ito, M., Nakano, M., Tsuchihashi, K., Ota, S. I., Wada, N., Hiroshi, U., ariyama, H., Kusaba, H., Niiro, H., Akashi, K. & Baba, E., Oct 1 2018, In : Cancer Science. 109, 10, p. 3032-3042 11 p.

Research output: Contribution to journalArticle

Th1 Cells
Melanoma
T-Lymphocytes
Antibodies
Phenotype

A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapy

Kumagai, H., Kusaba, H., Yamanaka, T., Nio, K., Inadomi, K., Takayoshi, K., Ito, M., Tamura, S., Makiyama, A., Makiyama, C., Hirano, G., Shibata, Y., Shirakawa, T., Mitsugi, K., ariyama, H., Esaki, T., Akashi, K. & Baba, E., Jun 1 2018, In : Medicine (United States). 97, 25, e11042.

Research output: Contribution to journalArticle

fosaprepitant
Dexamethasone
Antiemetics
Drug Therapy
Neoplasms
1 Citation (Scopus)

E-cadherin regulates proliferation of colorectal cancer stem cells through NANOG

Tamura, S., Isobe, T., ariyama, H., Nakano, M., Kikushige, Y., Takaishi, S., Kusaba, H., Takenaka, K., Ueki, T., Nakamura, M., Akashi, K. & Baba, E., Aug 1 2018, In : Oncology reports. 40, 2, p. 693-703 11 p.

Research output: Contribution to journalArticle

Neoplastic Stem Cells
Cadherins
Colorectal Neoplasms
Cyclin D1
Embryonic Stem Cells